The LCADA Way provides a Medication Assisted Treatment (MAT) model. An individual addicted to Opioids (Heroin, Morphine, or Prescription Narcotics) may be prescribed Suboxone, Subutex (pregnant women) or Vivitrol (Naltrexone). Medication in conjunction with traditional counseling has proven highly effective in treating individuals addicted to Opioids.
A physician will review your medical history and recommend the proper treatment. Once accepted into the program the individual must commit to:
- Treatment recommendations, which may include Residential or Intensive outpatient treatment. Proper attendance is required.
- Obtain stable housing
- Maintain 12-step meetings with verification
- Obtain a home group and sponsor
- Random urine drug screens
- Pre-natal care will be required for all women utilizing Subutex
Suboxone is used to help suppress the withdrawal symptoms and cravings associated with Opioid use. Suboxone is not to be used indefinitely and only in conjunction with counseling.
Subutex is used to treat pregnant women who are addicted to Opioids. Depending on the individual, Subutex will be prescribed through the entire pregnancy and while breast feeding.
Naltrexone and Vivitrol are opioid blockers prescribed by a physician to treat Opioid addiction, in combination with intensive counseling and other recovery services.
Naltrexone (pill form) and Vivitrol (monthly intramuscular injection) are both non-narcotic, non-addictive substances that create a blockade, preventing other Opioids of abuse from binding to the Opioid receptors in the brain.
Getting started: Adults dependent on Opioids must have successfully completed detoxification. Naltrexone or Vivitrol can be initiated approximately 7 to 10 days after last use.